Skip to main content

Publications searcher

The science produced by our scientists is very important. In 2022, 1,629 papers were published in scientific journals with a global impact factor of over 15,000 points.

RNA-binding proteins: underestimated contributors in tumorigenesis.

PMID: 35124196
Journal: SEMINARS IN CANCER BIOLOGY
Year: 2022
Reference: Semin Cancer Biol. 2022 Feb 3. pii: S1044-579X(22)00020-7. doi: 10.1016/j.semcancer.2022.01.010.
Impact factor: 15.707
Publication type: Paper in international publication
Authors: LLeonart, M E; Kondoh, H; Garcia-Mayea, Y; Zhao, Y; Mir, C; Paciucci, R et al.
DOI: 10.1016/j.semcancer.2022.01.010

Robotic abdominal resection of tailgut cysts - a technical note with step-by-step description.

PMID: 35133714
Journal: Colorectal Disease
Year: 2022
Reference: Colorectal Dis. 2022 Jun;24(6):793-796. doi: 10.1111/codi.16088. Epub 2022 Feb 23.
Impact factor: 3.788
Publication type: Paper in international publication
Authors: Solis-Pena, Alejandro; Ngu, Lena Ws; Kraft Carre, Miquel; Jurado, Maria Jose Gomez; Vallribera Valls, Francesc; Pellino, Gianluca; Espin-Basany, Eloy et al.
DOI: 10.1111/codi.16088

Robotic Abdominal Surgery and COVID-19: A Systematic Review of Published Literature and Peer-Reviewed Guidelines during the SARS-CoV-2 Pandemic.

PMID: 35683346
Journal: Journal of Clinical Medicine
Year: 2022
Reference: J Clin Med. 2022 May 24;11(11). pii: jcm11112957. doi: 10.3390/jcm11112957.
Impact factor: 4.242
Publication type: Review in international publication
Authors: Pata, Francesco, Pellino, Gianluca, Croghan, Stefanie, Fleming, Christina A, Fullard, Anna et al.
DOI: 10.3390/jcm11112957

Robotic and laparoscopic Roux-en-Y gastric bypass after learning curve: 30-day and 12-month outcomes.

PMID: 35218480
Journal: Journal of robotic surgery
Year: 2022
Reference: J Robot Surg. 2022 Feb 26. pii: 10.1007/s11701-022-01384-y. doi: 10.1007/s11701-022-01384-y.
Impact factor: 0
Publication type: Review in international publication
Authors: Roriz-Silva, Renato, Vilallonga, Ramon, Fort, Jose Manuel, Khoraki, Jad, de Gordejuela, Amador Garcia Ruiz, Gonzalez, Oscar, Caubet, Enric, Rodriguez-Luna, Maria Rita, Armengol, Manel et al.
DOI: 10.1007/s11701-022-01384-y

Robotic surgery in emergency setting: 2021 WSES position paper.

PMID: 35057836
Journal: World Journal of Emergency Surgery
Year: 2022
Reference: World J Emerg Surg. 2022 Jan 20;17(1):4. doi: 10.1186/s13017-022-00410-6.
Impact factor: 5.469
Publication type: Review in international publication
Authors: Pikoulis, Manos, Ansaloni, Luca, Biffl, Walter, Chiara, Osvaldo, Ceccarelli, Graziano, Coccolini, Federico, Cicuttin, Enrico, D'Hondt, Mathieu, Di Saverio, Salomone, Diana, Michele et al.
DOI: 10.1186/s13017-022-00410-6

Robotic Surgery in Pediatric Urology: A Critical Appraisal of the GECI and SIVI Consensus of European Experts.

PMID: 35796702
Journal: Journal of Laparoendoscopic & Advanced Surgical Te
Year: 2022
Reference: J Laparoendosc Adv Surg Tech A. 2022 Jul 7. doi: 10.1089/lap.2021.0837.
Impact factor: 1.878
Publication type: Paper in international publication
Authors: Ghoneimi, Alaa El; Chiarenza, Fabio; Castagnetti, Marco; Escolino, Maria; Scuderi, Maria Grazia; Esposito, Ciro; Blanc, Thomas; Lardy, Hubert; Masieri, Lorenzo; Fourcade, Laurent et al.
DOI: 10.1089/lap.2021.0837

Robotic-assisted lobectomy after bilateral lung transplantation.

PMID: 35134956
Journal: Interactive Cardiovascular and Thoracic Surgery
Year: 2022
Reference: Interact Cardiovasc Thorac Surg. 2022 May 2;34(5):927-929. doi: 10.1093/icvts/ivac027.
Impact factor: 1.905
Publication type: Letter or abstract
Authors: Romero-Vielva, Laura; Ascanio-Gosling, Fernando; Gonzalez-Tallada, Anna; Rosado-Rodriguez, Joel et al.
DOI: 10.1093/icvts/ivac027

Role of telemedicine in the management of oral anticoagulation in atrial fibrillation: a practical clinical approach.

PMID: 35822847
Journal: Future cardiology
Year: 2022
Reference: Future Cardiol. 2022 Jul 13. doi: 10.2217/fca-2022-0044.
Impact factor: 0
Publication type: Review in international publication
Authors: Barrios, Vivencio, Cinza-Sanjurjo, Sergio, Garcia-Alegria, Javier, Freixa-Pamias, Roman, Llordachs-Marques, Frederic, Molina, Carlos A, Santamaria, Amparo, Suarez Fernandez, Carmen, Vivas, David et al.
DOI: 10.2217/fca-2022-0044

Routine Gadolinium Use for MRI Follow-up of Multiple Sclerosis: Counterpoint-Gadolinium Should Not Always Be Used to Assess Disease Activity.

PMID: 34786958
Journal: AMERICAN JOURNAL OF ROENTGENOLOGY
Year: 2022
Reference: AJR Am J Roentgenol. 2022 Jul;219(1):26-27. doi: 10.2214/AJR.21.27069. Epub 2021 Nov 17.
Impact factor: 3.959
Publication type: Letter whit IF
Authors: Rovira, Alex, Auger, Cristina et al.
DOI: 10.2214/AJR.21.27069

RRM1 variants cause a mitochondrial DNA maintenance disorder via impaired de novo nucleotide synthesis.

PMID: 35617047
Journal: JOURNAL OF CLINICAL INVESTIGATION
Year: 2022
Reference: J Clin Invest. 2022 Jul 1;132(13). pii: 145660. doi: 10.1172/JCI145660.
Impact factor: 14.808
Publication type: Paper in international publication
Authors: Smeets, H J M, Gorman, Grainne S, Bonnen, Penelope E, Taylor, Robert W, Hirano, Michio, Chinnery, Patrick F, Rodenburg, Richard J, Tanji, Kurenai, Shintaku, Jonathan, Pernice, Wolfgang M et al.
DOI: 10.1172/JCI145660

Rucaparib versus standard-of-care chemotherapy in patients with relapsed ovarian cancer and a deleterious BRCA1 or BRCA2 mutation (ARIEL4): an international, open-label, randomised, phase 3 trial.

PMID: 35298906
Journal: LANCET ONCOLOGY
Year: 2022
Reference: Lancet Oncol. 2022 Apr;23(4):465-478. doi: 10.1016/S1470-2045(22)00122-X. Epub 2022 Mar 14.
Impact factor: 41.316
Publication type: Paper in international publication
Authors: de Melo, Andreia Cristina, Shparyk, Yaroslav, Rakhmatullina, Irina, Bondarenko, Igor, Colombo, Nicoletta, Svintsitskiy, Valentyn, Biela, Luciano, Nechaeva, Marina, Lorusso, Domenica, Scambia, Giovanni et al.
DOI: 10.1016/S1470-2045(22)00122-X

Rumination syndrome, critical review.

PMID: 34023479
Journal: Gastroenterologia y Hepatologia
Year: 2022
Reference: Gastroenterol Hepatol. 2022 Feb;45(2):155-163. doi: 10.1016/j.gastrohep.2021.03.013. Epub 2021 May 21.
Impact factor: 2.102
Publication type: Review in national publication
Authors: Alcala-Gonzalez, L G; Serra, X; Barba, E et al.
DOI: 10.1016/j.gastrohep.2021.03.013

Sacituzumab govitecan as second-line treatment for metastatic triple-negative breast cancer-phase 3 ASCENT study subanalysis.

PMID: 35680967
Journal: npj Breast Cancer
Year: 2022
Reference: NPJ Breast Cancer. 2022 Jun 9;8(1):72. doi: 10.1038/s41523-022-00439-5.
Impact factor: 6.923
Publication type: Paper in international publication
Authors: Cortes, Javier, Carey, Lisa A, Loirat, Delphine, Punie, Kevin, Bardia, Aditya, Dieras, Veronique, Dalenc, Florence, Diamond, Jennifer R, Fontaine, Christel, Rugo, Hope S et al.
DOI: 10.1038/s41523-022-00439-5

Safety and antitumor activity of dostarlimab in patients with advanced or recurrent DNA mismatch repair deficient/microsatellite instability-high (dMMR/MSI-H) or proficient/stable (MMRp/MSS) endometrial cancer: interim results from GARNET-a phase I, single-arm study.

PMID: 35064011
Journal: Journal for ImmunoTherapy of Cancer
Year: 2022
Reference: J Immunother Cancer. 2022 Jan;10(1). pii: jitc-2021-003777. doi: 10.1136/jitc-2021-003777.
Impact factor: 13.751
Publication type: Paper in international publication
Authors: Gilbert, Lucy, Tinker, Anna V, Brown, Jubilee, Mathews, Cara, Press, Joshua, Sabatier, Renaud, O'Malley, David M, Samouelian, Vanessa, Boni, Valentina, Duska, Linda et al.
DOI: 10.1136/jitc-2021-003777

Safety and Effectiveness of Isavuconazole Treatment for Fungal Infections in Solid Organ Transplant Recipients (ISASOT Study).

PMID: 35171022
Journal: Microbiology Spectrum
Year: 2022
Reference: Microbiol Spectr. 2022 Feb 23;10(1):e0178421. doi: 10.1128/spectrum.01784-21. Epub 2022 Feb 16.
Impact factor: 7.171
Publication type: Paper in international publication
Authors: Monforte, Arnau, Los-Arcos, Ibai, Martin-Gomez, Maria Teresa, Campany-Herrero, David, Sacanell, Judith, Berastegui, Cristina, Marquez-Algaba, Ester, Sempere, Abiu, Nuvials, Xavier, Castells, Lluis et al.
DOI: 10.1128/spectrum.01784-21

Safety and Efficacy of Devices Delivering Inhaled Antibiotics among Adults with Non-Cystic Fibrosis Bronchiectasis: A Systematic Review and a Network Meta-Analysis.

PMID: 35203878
Journal: Antibiotics-Basel
Year: 2022
Reference: Antibiotics (Basel). 2022 Feb 19;11(2). pii: antibiotics11020275. doi: 10.3390/antibiotics11020275.
Impact factor: 4.639
Publication type: Review in international publication
Authors: Tejada, Sofia, Forero, Carlos G, Gallego, Miguel, Soriano, Joan B, Cardinal-Fernandez, Pablo A, Ehrmann, Stephan, Rello, Jordi, Ramirez-Estrada, Sergio et al.
DOI: 10.3390/antibiotics11020275

Safety and efficacy of eptinezumab for migraine prevention in patients with two-to-four previous preventive treatment failures (DELIVER): a multi-arm, randomised, double-blind, placebo-controlled, phase 3b trial.

PMID: 35716692
Journal: LANCET NEUROLOGY
Year: 2022
Reference: Lancet Neurol. 2022 Jul;21(7):597-607. doi: 10.1016/S1474-4422(22)00185-5.
Impact factor: 44.182
Publication type: Paper in international publication
Authors: Lanteri-Minet, Michel; Pozo-Rosich, Patricia; Ettrup, Anders; Christoffersen, Cecilie Laurberg; Josiassen, Mette Krog; Phul, Ravinder; Sperling, Bjorn; Ashina, Messoud et al.
DOI: 10.1016/S1474-4422(22)00185-5

Safety and efficacy of once-daily risdiplam in type 2 and non-ambulant type 3 spinal muscular atrophy (SUNFISH part 2): a phase 3, double-blind, randomised, placebo-controlled trial.

PMID: 34942136
Journal: LANCET NEUROLOGY
Year: 2022
Reference: Lancet Neurol. 2022 Jan;21(1):42-52. doi: 10.1016/S1474-4422(21)00367-7.
Impact factor: 44.182
Publication type: Paper in international publication
Authors: Goemans, Nathalie; Mercuri, Eugenio; Deconinck, Nicolas; Mazzone, Elena S; Nascimento, Andres; Oskoui, Maryam; Saito, Kayoko; Vuillerot, Carole; Baranello, Giovanni; Boespflug-Tanguy, Odile et al.
DOI: 10.1016/S1474-4422(21)00367-7

Safety and feasibility of stem cell boost as a salvage therapy for severe hematotoxicity after CD19 CAR T-cell therapy.

PMID: 35793454
Journal: Blood Advances
Year: 2022
Reference: Blood Adv. 2022 Jun 24. pii: 485692. doi: 10.1182/bloodadvances.2022007776.
Impact factor: 6.799
Publication type: Paper in international publication
Authors: Subklewe, Marion; Barba, Pere; Bachy, Emmanuel; von Bergwelt-Baildon, Michael; Sohlbach, Kristina; Schmidt, Christian; Blumenberg, Viktoria; Schafer, Jonas A; Naumann, Ralph; Hernani, Rafael et al.
DOI: 10.1182/bloodadvances.2022007776

Safety and preliminary activity results of the GATTO study, a phase Ib study combining the anti-TA-MUC1 antibody gatipotuzumab with the anti-EGFR tomuzotuximab in patients with refractory solid tumors.

PMID: 35397434
Journal: ESMO Open
Year: 2022
Reference: ESMO Open. 2022 Apr;7(2):100447. doi: 10.1016/j.esmoop.2022.100447. Epub 2022 Apr 6.
Impact factor: 6.54
Publication type: Paper in international publication
Authors: Ochsenreither, S, Fiedler, W M, Conte, G D, Macchini, M, Matos, I, Habel, B, Ahrens-Fath, I, Raspagliesi, F, Keilholz, U, Rolling, C et al.
DOI: 10.1016/j.esmoop.2022.100447

Safety of Obtaining an Extra Biobank Kidney Biopsy Core.

PMID: 35268550
Journal: Journal of Clinical Medicine
Year: 2022
Reference: J Clin Med. 2022 Mar 7;11(5). pii: jcm11051459. doi: 10.3390/jcm11051459.
Impact factor: 4.242
Publication type: Paper in international publication
Authors: Mast, Richard, Vergara, Ander, Agraz, Irene, Leon, Juan Carlos, Bolufer, Monica, Gabaldon, Maria-Alejandra, Seron, Daniel, Bestard, Oriol, Soler, Maria Jose, Garcia-Carro, Clara et al.
DOI: 10.3390/jcm11051459

Safety of Tepotinib in Patients With MET Exon 14 Skipping NSCLC and Recommendations for Management.

PMID: 35466070
Journal: Clinical Lung Cancer
Year: 2022
Reference: Clin Lung Cancer. 2022 Jun;23(4):320-332. doi: 10.1016/j.cllc.2022.03.002. Epub 2022 Mar 17.
Impact factor: 4.785
Publication type: Paper in international publication
Authors: Veillon, Remi, Sakai, Hiroshi, Le, Xiuning, Felip, Enriqueta, Cortot, Alexis B, Smit, Egbert F, Park, Keunchil, Griesinger, Frank, Britschgi, Christian, Wu, Yi-Long et al.
DOI: 10.1016/j.cllc.2022.03.002

Safety, pharmacokinetic, pharmacodynamic and clinical activity of molibresib for the treatment of NUT carcinoma and other cancers: results of a phase I/II open-label, dose escalation study.

PMID: 34724226
Journal: INTERNATIONAL JOURNAL OF CANCER
Year: 2022
Reference: Int J Cancer. 2022 Mar 15;150(6):993-1006. doi: 10.1002/ijc.33861. Epub 2021 Nov 26.
Impact factor: 7.396
Publication type: Paper in international publication
Authors: Datta, Antara, Foley, Shawn W, McCabe, Michael T, Wu, Yuehui, Horner, Thierry, Kremer, Brandon E, Dhar, Arindam, O'Dwyer, Peter J, Shapiro, Geoffrey I, Piha-Paul, Sarina A et al.
DOI: 10.1002/ijc.33861

Safety, pharmacokinetics, and antitumor activity of the anti-CEACAM5-DM4 antibody-drug conjugate tusamitamab ravtansine (SAR408701) in patients with advanced solid tumors: First-in-human dose-escalation study.

PMID: 35026412
Journal: ANNALS OF ONCOLOGY
Year: 2022
Reference: Ann Oncol. 2022 Apr;33(4):416-425. doi: 10.1016/j.annonc.2021.12.012. Epub 2022 Jan 10.
Impact factor: 32.976
Publication type: Paper in international publication
Authors: Gazzah, A, Bedard, P L, Hierro, C, Kang, Y-K, Abdul Razak, A, Ryu, M-H, Demers, B, Fagniez, N, Henry, C, Hospitel, M et al.
DOI: 10.1016/j.annonc.2021.12.012